Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 months
Awards & highlights
Study Summary
This trial will study how well a new device, the BTL-785-7 applicator, works to improve facial wrinkles and appearance.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Histological examination
Secondary outcome measures
Evaluation of Overall Facial Appearance According to GAIS
Evaluation of Wrinkle Severity
Subject Satisfaction
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: BTL-785-7 TreatmentExperimental Treatment1 Intervention
Subjects will be enrolled for an active treatment with BTL-785F device (BTL-785-7 applicator) for non-invasive facial rejuvenation.
Group II: ControlActive Control1 Intervention
One subject will serve as a control.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BTL-785-7
2023
N/A
~110
Find a Location
Who is running the clinical trial?
BTL Industries Ltd.Lead Sponsor
51 Previous Clinical Trials
1,795 Total Patients Enrolled
12 Trials studying Wrinkles
370 Patients Enrolled for Wrinkles
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger